Stocks · News reference

The9 Says Investee Nanyang Biologics Received SEC Notice Of Effectiveness For Form F-4 Ahead Of Nasdaq Listing At $1.5B Pre-Transaction Valuation; Expects To Own 15% To 16% Of Combined Company

Aug 11, 2026, 12:32 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 27, 2026, 9:07 PMBenzinga Insights
12 Information Technology Stocks Moving In Thursday's After-Market Session
Gainers Elastic (NYSE:ESTC) shares increased by 16.9% to $97.92 during Thursday's after-market session. The market value of their outstanding shares is at $8.3 billion. The company's, Q1 earnings came out
ADSK AMCI CANG CCTG DGNX
BenzingaAug 24, 2026, 1:36 PMBenzinga Newsdesk
The9 Q2 EPS $0.01, Sales $712.000K
The9 (NASDAQ:NCTY) reported quarterly earnings of $0.01 per share. The company reported $712.000 thousand in sales this quarter.
NCTY
BenzingaAug 21, 2026, 5:41 PMBenzinga Newsdesk
The9 shares are trading higher. The company announced its investee Nanyang Biologics cleared a key step toward a planned Nasdaq listing after RF Acquisition shareholders approved their merger.
NCTY
BenzingaAug 21, 2026, 12:31 PMBenzinga Newsdesk
The9 Says RF Acquisition Corp II Shareholders Approved Business Combination With Nanyang Biologics On August 19; Expects To Hold About 15% To 16% Of Combined Nasdaq-Listed Company
NCTY